Literature DB >> 3233231

Intravenous cocaine: psychiatric effects, biological mechanisms.

M A Sherer1.   

Abstract

Volunteer addicts were administered iv loading doses of cocaine, followed by 4-hr cocaine infusions that maintained steady-state conditions. The loading doses were followed by the "rush" and "high" subjective effects that users typically experience; cocaine infusions maintained the experience of drug "high", but not "rush". In a subsequent experiment, haloperidol pretreatment did not alter cocaine "rush" but partially attenuated cocaine "high." During cocaine infusions, we also noted suspicious and paranoid behavior, which were blindly rated by nurses. During one of the infusion conditions, the degree of suspiciousness observed was related to the amount of cocaine previously administered. Although cardiovascular responses to cocaine were marked, we found no alterations in plasma catecholamines following cocaine administrations. Baseline homovanillic acid (HVA) levels, however, were related to the degree of suspiciousness observed following cocaine dosing. The potential contributions of dopaminergic systems and physiological sensitization to the development of the psychiatric toxicity of cocaine are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3233231     DOI: 10.1016/0006-3223(88)90222-3

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Placebo responses to cocaine administration in humans: effects of prior administrations and verbal instructions.

Authors:  C Muntaner; N G Cascella; K M Kumor; C Nagoshi; R Herning; J Jaffe
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion.

Authors:  Marco Leyton; Marije aan het Rot; Linda Booij; Glen B Baker; Simon N Young; Chawki Benkelfat
Journal:  J Psychiatry Neurosci       Date:  2007-03       Impact factor: 6.186

Review 3.  Animal models of drug craving.

Authors:  A Markou; F Weiss; L H Gold; S B Caine; G Schulteis; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Mood responses of remitted schizophrenics to methylphenidate infusion.

Authors:  D Robinson; D Mayerhoff; J Alvir; T Cooper; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

5.  Cocaine and Psychiatric Symptoms.

Authors:  W Alexander Morton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  1999-08

6.  Methylphenidate Abuse and Psychiatric Side Effects.

Authors:  W Alexander Morton; Gwendolyn G. Stockton
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-10

Review 7.  Clinical features and management of intoxication due to hallucinogenic drugs.

Authors:  J B Leikin; A J Krantz; M Zell-Kanter; R L Barkin; D O Hryhorczuk
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

8.  The effectiveness of treatments for cocaine dependence in schizophrenic patients: a systematic review.

Authors:  Pamela Sabioni; Anna Carolina Ramos; Jose Carlos F Galduróz
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363

9.  Trends of Cocaine Use and Manifestations in Hospitalized Patients: A Cross-Sectional Study.

Authors:  Karthik Gangu; Aniesh Bobba; Sanket D Basida; Sindhu Avula; Harleen Chela; Simranjit Singh
Journal:  Cureus       Date:  2022-02-10

10.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.